Korean J Med.  2016 Aug;91(1):12-17. 10.3904/kjm.2016.91.1.12.

The Impact of the SPRINT Trial on Hypertension Guidelines

Affiliations
  • 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. skimw@chonnam.ac.kr

Abstract

The most recent revision of the blood pressure guidelines adopted less aggressive blood pressure targets, particularly in patients with diabetes and chronic kidney disease, and the elderly. However, the Systolic Blood Pressure Intervention Trial (SPRINT) reported that lowering the systolic blood pressure to <120 mmHg resulted in a decreased risk of cardiovascular disease, compared with lowering the SBP to <140 mmHg, in adults with hypertension but without diabetes. This will likely lead to many changes in clinical practice. Such lowering of systolic blood pressure would benefit some categories of hypertensive patients at an increased risk of cardiovascular disease.

Keyword

Hypertension; SPRINT; Blood pressure

MeSH Terms

Adult
Aged
Blood Pressure
Cardiovascular Diseases
Humans
Hypertension*
Renal Insufficiency, Chronic
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr